- Condition: Relapsing-Remitting Multiple Sclerosis
Interventions: Drug: Glatiramer Acetate; Drug: Matching placebo
Sponsors: Teva Pharmaceutical Industries; Teva Pharmaceutical Industries
Recruiting - verified May 2012 - Condition: Multiple Sclerosis
Intervention: Other: ARMS Questionnaire
Sponsors: Questcor Pharmaceuticals, Inc.; Questcor Pharmaceuticals, Inc.
Recruiting - verified March 2012 - Condition: Relapsing-remitting Multiple Sclerosis
Intervention:
Sponsors: Biogen Idec; Biogen Idec
Recruiting - verified May 2012 - Condition: Multiple Sclerosis
Interventions: Drug: Ofatumumab 3mg; Drug: Ofatumumab 30mg; Drug: Ofatumumab 60mg; Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified May 2012 - Condition: Pediatric Multiple Sclerosis
Intervention:
Sponsors: University of California, San Francisco; University of California, San Francisco; Stony Brook University; Massachusetts General Hospital; State University of New York at Buffalo; University of Alabama at Birmingham; Mayo Clinic; Texas Children's Hospital; University of Washington; Loma Linda University; University of Utah
Recruiting - verified March 2012 - Conditions: Central Neuropathic Pain; Multiple Sclerosis
Intervention: Drug: AVP-923
Sponsors: Avanir Pharmaceuticals; Avanir Pharmaceuticals
Recruiting - verified May 2012 - Condition: Multiple Sclerosis
Intervention: Drug: Lithium Carbonate
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified May 2012 - Condition: Multiple Sclerosis Relapse
Interventions: Drug: Teriflunomide (HMR1726); Drug: Matching placebo
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified May 2012 - Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: ocrelizumab; Drug: Rebif; Drug: ocrelizumab placebo; Drug: Rebif placebo
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Multiple Sclerosis
Interventions: Behavioral: CI Therapy; Behavioral: CAM treatments
Sponsors: National Multiple Sclerosis Society; National Multiple Sclerosis Society
Recruiting - verified July 2011 - Condition: Multiple Sclerosis
Intervention:
Sponsors: University of Alabama at Birmingham; University of Alabama at Birmingham; Consortium of Multiple Sclerosis Centers
Recruiting - verified April 2012 - Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide (HMR1726); Drug: Placebo
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified May 2012
 |
Join Clinical Trials in Alabama for Multiple Sclerosis |
